| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| hydroflumethiazide | sodium/potassium-transporting atpase subunit alpha-1 | small molecule | NA | drugbank | Hypertensive disease[MeSHID:D006973] Disease Management[MeSHID:D019468] Edema[MeSHID:D004487] Liver Cirrhosis[MeSHID:D008103] Congestive heart failure[MeSHID:D006333] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational,withdrawn | inducer |
| hydroflumethiazide | carbonic anhydrase 1 | small molecule | NA | drugbank | Hypertensive disease[MeSHID:D006973] Disease Management[MeSHID:D019468] Edema[MeSHID:D004487] Liver Cirrhosis[MeSHID:D008103] Congestive heart failure[MeSHID:D006333] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational,withdrawn | inhibitor |
| hydroflumethiazide | carbonic anhydrase 12 | small molecule | NA | drugbank | Hypertensive disease[MeSHID:D006973] Disease Management[MeSHID:D019468] Edema[MeSHID:D004487] Liver Cirrhosis[MeSHID:D008103] Congestive heart failure[MeSHID:D006333] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational,withdrawn | inhibitor |
| hydroflumethiazide | carbonic anhydrase 2 | small molecule | NA | drugbank | Hypertensive disease[MeSHID:D006973] Disease Management[MeSHID:D019468] Edema[MeSHID:D004487] Liver Cirrhosis[MeSHID:D008103] Congestive heart failure[MeSHID:D006333] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational,withdrawn | inhibitor |
| hydroflumethiazide | carbonic anhydrase 4 | small molecule | NA | drugbank | Hypertensive disease[MeSHID:D006973] Disease Management[MeSHID:D019468] Edema[MeSHID:D004487] Liver Cirrhosis[MeSHID:D008103] Congestive heart failure[MeSHID:D006333] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational,withdrawn | inhibitor |
| hydroflumethiazide | carbonic anhydrase 7 | small molecule | NA | drugbank | Hypertensive disease[MeSHID:D006973] Disease Management[MeSHID:D019468] Edema[MeSHID:D004487] Liver Cirrhosis[MeSHID:D008103] Congestive heart failure[MeSHID:D006333] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational,withdrawn | inhibitor |
| hydroflumethiazide | carbonic anhydrase 9 | small molecule | NA | drugbank | Hypertensive disease[MeSHID:D006973] Disease Management[MeSHID:D019468] Edema[MeSHID:D004487] Liver Cirrhosis[MeSHID:D008103] Congestive heart failure[MeSHID:D006333] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational,withdrawn | inhibitor |
| hydroflumethiazide | calcium-activated potassium channel subunit alpha-1 | small molecule | NA | drugbank | Hypertensive disease[MeSHID:D006973] Disease Management[MeSHID:D019468] Edema[MeSHID:D004487] Liver Cirrhosis[MeSHID:D008103] Congestive heart failure[MeSHID:D006333] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational,withdrawn | inducer |
| hydroflumethiazide | solute carrier family 12 member 1 | small molecule | Successful target | TTD , drugbank , DGIDB | Hypertensive disease[MeSHID:D006973] Disease Management[MeSHID:D019468] Edema[MeSHID:D004487] Liver Cirrhosis[MeSHID:D008103] Congestive heart failure[MeSHID:D006333] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
9.09 | approved,investigational,withdrawn | inhibitor |
| click here to return to the previous page | ||||||||